Sign in Subscribe
All

Latest Positions: Beatens and Biotech

Cody Willard

Cody Willard

— 2 min read

Here are the remaining stocks from the list my latest personal portfolio positions and most of the hedge fund positions with updated commentary and ratings for each position.

The ratings for each position go from 1 to 10, 1 being “Get out of this position now!” and 10 being “Sell the farm, I’ve found a perfect investment.” The positions that are bolded are those that I consider to be “core” holdings and am unlikely to ever sell out of them entirely.

Longs –

Beatens Basket

    • IONQ Ioniq – A quantum computing play that has no revenue and probably won’t for another year or two. If they end up delivering on their technological roadmap, this could be huge. But it’s also the kind of stock that this market hates right now so we need to be careful.
    • CGC Canopy Growth – A well-run, well-capitalized cannabis stock, which is probably the only sector that’s performed even worse than biotech has over the last couple years. Which is why I’ve started building a small position here.
    • Kyndral KD – If this company can turn off its unprofitable contracts when they come up for renewal in the next year or two, the profits on nearly $20 billion of sales could be significant. With a $4 billion market cap the markets don’t think these guys will even create any value. The biggest risk is if these management here is afraid to take risks.
    • SKLZ Skillz – If the company’s not a fraud, it’s really cheap here. The growth could be big for the next two or three years and the margins are fantastic.
    • Origin ORGN – Like with Ioniq, this is a conceptual business that has no revenue and probably won’t for another year or two. If they end up delivering on their technological roadmap, this could be huge. But it’s also the kind of stock that this market hates right now so we need to be careful.

Biotech basket Biotech is acting terrible as it has for a long time now but that’s also why I’m finding some interesting opportunities to build a basket of biotech stocks that have some chances of big success if they end up delivering on their promise.

      • PRVB Providian (7) – I’m nibbling a little more of this one in the hedge fund and personal account here.
      • INFI Infinity (7) – The company’s been updating their data and filings and things continue to look promising although there’s certainly plenty risk in this name too. I’m nibbling a little more of this one in the hedge fund and personal account here.
      • CDXS Codexis (7) – I’m nibbling a little more of this one in the hedge fund and personal account here.
  • ETH Ethereum (8) – The world’s open sourced, blockchain-based supercomputer continues to enable new innovations in crypto and computing and NFTs and etc etc. I’ve owned ETH since it was less than two years old and I plan on holding most of it forever.

Be careful out there!

Read more